Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...

On June 25, 2025, two securities class action lawsuits were filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of ...

Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and ...

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

According to data from eToro, leading the list was telehealth platform, Hims & Hers Health, which surged 85 per cent in ...

The federal government's investigation into a recall of Salmonella-contaminated brown cage-free and certified-organic eggs ...

Whether identifying as Republicans or Democrats, about 70% of adults surveyed say health insurers exert too much influence ...

It is unclear how the Trump administration will consider affordability when reviewing a drug, as prices are usually ...